Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Women with PCOS have a similar chance of getting pregnant using assisted reproductive treatment as those without PCOS.

Mesenchymal stem cells help improve skin healing and rejuvenation.

MicroRNAs can help regenerate hair by influencing stem cells and immune responses, but delivery challenges exist.

Upadacitinib can cause hypersensitivity that worsens ulcerative colitis symptoms.

Upadacitinib improved multiple immune-related conditions in one patient.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

JAK inhibitors effectively regrow hair in alopecia areata but hair loss often returns after stopping treatment.

Transforming skin disease treatment requires new strategies, better drug models, and patient-focused research.

Topical ruxolitinib quickly improves non-segmental vitiligo.

α-Mangostin can naturally lighten skin by reducing melanin.

A combined treatment with microneedling and vitamin D3 led to complete hair regrowth in a woman with stubborn patch alopecia areata.

Tofacitinib is effective and safe for treating severe alopecia areata.

Baricitinib effectively regrows hair in severe alopecia areata cases.

Tofacitinib effectively promotes hair regrowth in alopecia areata with minimal side effects.

Inhibiting prolactin reduces hair follicle activation in cashmere goats.

Baricitinib helps regrow hair in severe alopecia areata and is safe, but more research is needed.

Janus kinase inhibitors effectively treat alopecia areata but may cause relapses and have long-term safety concerns.

JAK inhibitors can help regrow hair in alopecia areata but have potential long-term risks and require careful monitoring.

Placental stem cell exosome therapy improves hair growth and reduces hair loss.

A 589 nm laser increases IL-2 and IFN-y gene expression in human T-cells.

Ritlecitinib effectively regrows hair in severe alopecia areata and is well tolerated.

Increased cell death and reduced cell growth in hair follicles contribute to baldness.

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

Tofacitinib successfully treated vitiligo in a patient with lupus without side effects.

Upadacitinib may effectively treat alopecia areata without side effects.

The study suggests that hypothyroidism may cause alopecia areata.

Baricitinib may effectively treat oral lichen planus.

Tofacitinib may be safe and effective for treating certain skin conditions in children.

Upadacitinib effectively treated a patient with multiple inflammatory conditions.

Tofacitinib effectively reduced hair loss in alopecia areata patients without adverse effects.